恩帕吉菲
医学
非酒精性脂肪肝
随机对照试验
内科学
2型糖尿病
糖尿病
胃肠病学
脂肪肝
非酒精性脂肪性肝炎
内分泌学
疾病
作者
Mohammad Shafi Kuchay,Sonal Krishan,Sunil Kumar Mishra,Khalid Farooqui,Manish Kumar Singh,Jasjeet Singh Wasir,Beena Bansal,Parjeet Kaur,Ganesh Jevalikar,Harmendeep Kaur Gill,Narendra S. Choudhary,Ambrish Mithal
出处
期刊:Diabetes Care
[American Diabetes Association]
日期:2018-06-12
卷期号:41 (8): 1801-1808
被引量:605
摘要
When included in the standard treatment for type 2 diabetes, empagliflozin reduces liver fat and improves ALT levels in patients with type 2 diabetes and NAFLD.
科研通智能强力驱动
Strongly Powered by AbleSci AI